GLP-1 helps lower blood glucose (blood sugar) by triggering insulin release
All of this happens before patients notice anything
A randomised clinical trial involving patients with type 2 diabetes aged 70 years revealed that multifactorial interventions, including diet, physical exercise and optimal control of glucose and blood pressure, significantly improved the SPPB score after 12 months [236]
Just for this trait, overdosage is very difficult, while deficiency can cause severe health problems
When it is low, wound healing suffers, anaemia becomes more likely, and the risk profile for deep vein thrombosis shifts in the wrong direction
KLOW is not an FDA-approved treatment and no published clinical trial has evaluated the four-peptide combination together